Magnetization transfer measurements of exchange between hyperpolarized [1‐13C]pyruvate and [1‐13C]lactate in a murine lymphoma

Measurements of the conversion of hyperpolarized [1‐13C]pyruvate into lactate, in the reaction catalyzed by lactate dehydrogenase, have shown promise as a metabolic marker for the presence of disease and response to treatment. However, it is unclear whether this represents net flux of label from pyruvate to lactate or exchange of isotope between metabolites that are close to chemical equilibrium. Using saturation and inversion transfer experiments, we show that there is significant exchange of label between lactate and pyruvate in a murine lymphoma in vivo. The rate constants estimated from the magnetization transfer experiments, at specific points during the time course of label exchange, were similar to those obtained by fitting the changes in peak intensities during the entire exchange time course to a kinetic model for two‐site exchange. These magnetization transfer experiments may therefore provide an alternative and more rapid way of estimating flux between pyruvate and lactate to serial measurements of pyruvate and lactate 13C peak intensities following injection of hyperpolarized [1‐13C]pyruvate. Magn Reson Med 63:872–880, 2010. © 2010 Wiley‐Liss, Inc.

[1]  Ferdia A Gallagher,et al.  A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. , 2009, Neoplasia.

[2]  D. Spielman,et al.  Measuring Michaelis-Menten Kinetics of Hyperpolarized 13C1-Pyruvate Metabolism in a Single Bolus Injection , 2009 .

[3]  Craig R. Malloy,et al.  Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO  3− , 2008, Magnetic resonance in medicine.

[4]  Albert P. Chen,et al.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.

[5]  G. Radda,et al.  In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance , 2008, Proceedings of the National Academy of Sciences.

[6]  John Kurhanewicz,et al.  Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. , 2008, Magnetic resonance imaging.

[7]  Pernille R. Jensen,et al.  Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.

[8]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[9]  Albert P. Chen,et al.  Original contributions Feasibility of using hyperpolarized (1- 13 C)lactate as a substrate for in vivo metabolic 13 C MRSI studies , 2008 .

[10]  W. Lam,et al.  Kinetic Modeling of Hyperpolaized [ 1-13 C ] Pyruvate Metabolism in Blood , 2008 .

[11]  John M Pauly,et al.  Hyperpolarized C‐13 spectroscopic imaging of the TRAMP mouse at 3T—Initial experience , 2007, Magnetic resonance in medicine.

[12]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[13]  Jun Shen,et al.  In vivo 13C saturation transfer effect of the lactate dehydrogenase reaction , 2007, Magnetic resonance in medicine.

[14]  Jan Henrik Ardenkjaer-Larsen,et al.  Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. , 2006, Cancer research.

[15]  Matthew E Merritt,et al.  Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI , 2005, Magnetic resonance in medicine.

[16]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[17]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Detecting early response to cyclophosphamide treatment of RIF‐1 tumors using selective multiple quantum spectroscopy (SelMQC) and dynamic contrast enhanced imaging , 2003, NMR in biomedicine.

[19]  Ann Turner,et al.  In the Heart , 2001 .

[20]  Z. M. Bhujwalla,et al.  Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. , 1998, British Journal of Cancer.

[21]  J A Romijn,et al.  Lactate-pyruvate interconversion in blood: implications for in vivo tracer studies. , 1994, The American journal of physiology.

[22]  J R Griffiths,et al.  An assessment of 31P MRS as a method of measuring pH in rat tumours , 1992, NMR in biomedicine.

[23]  Y. Pocker,et al.  A comparative study of the enolization of pyruvate and the reversible dehydration of pyruvate hydrate , 1992 .

[24]  Kevin M. Brindle,et al.  NMR methods for measuring enzyme kinetics in vivo , 1988 .

[25]  L. Sauer,et al.  In vivo lactate production and utilization by Jensen sarcoma and Morris hepatoma 7288CTC. , 1986, Cancer research.

[26]  L. Sauer,et al.  Regulation of lactate production and utilization in rat tumors in vivo. , 1985, The Journal of biological chemistry.

[27]  I. Campbell,et al.  A p.m.r. isotope-exchange method for studying the kinetic properties of dehydrogenases in intact cells. , 1982, The Biochemical journal.

[28]  H A Krebs,et al.  Cytosolic phosphorylation potential. , 1979, The Journal of biological chemistry.

[29]  K. Laidler,et al.  Molecular kinetics of beef heart lactate dehydrogenase. , 1974, Biochemistry.

[30]  P. Boyer,et al.  EQUILIBRIUM REACTION RATES AND THE MECHANISMS OF BOVINE HEART AND RABBIT MUSCLE LACTATE DEHYDROGENASES. , 1964, The Journal of biological chemistry.

[31]  H. Mcconnell Reaction Rates by Nuclear Magnetic Resonance , 1958 .